{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

A survey to understand usage pattern of FDC Pregabalin & Nortriptyline for the treatment of neuropathic pain in India

Survey Questionnaire Form
Doctor’s details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Questionnaire

  1. How many patients of Neuropathic pain do you see in a month? *

  2. From your clinical experience, mention the most common type of Neuropathic pain patients that present to you at diagnosis? *

  3. Do you consider pregabalin as a first-line treatment for neuropathy? *

  4. What percentage of your neuropathy patients achieve satisfactory symptom relief with pregabalin alone? *

  5. In your practice, what proportion of neuropathy patients require combination therapy involving pregabalin? *

  6. What percentage of your neuropathy patients are currently prescribed FDC of pregabalin and nortriptyline treatment? *

  7. In your experience, how effective do you find FDC of pregabalin and nortriptyline in managing neuropathy symptoms? *
  8. On a scale of 1 to 5, How satisfied are you with the current dosing options available for FDC of pregabalin and nortriptyline? (5 being very satisfied) *

  9. In your experience, how quickly do patients typically respond to FDC of pregabalin and nortriptyline treatment? *

  10. Which factors are critical for choosing FDC of pregabalin and nortriptyline in neuropathic pain? *
  11. How often do you adjust the dosage of FDC of pregabalin and nortriptyline for optimal symptom management? *

  12. On average, how long do your patients remain on FDC of pregabalin and nortriptyline treatment? *

  13. What is your typical starting dose of this combination in neuropathy patients? *

  14. Do you prefer prescribing the fixed dose combination over giving pregabalin and nortriptyline separately? (If no, please specify reason.) *

  15. In your experience, does FDC of pregabalin and nortriptyline provide long-term benefits for peripheral neuropathy patients? *

  16. Have you observed any differences in treatment response based on patient’s age when prescribing FDC of pregabalin and nortriptyline in neuropathy patients? *

  17. Have you observed any differences in treatment response based on patient’s gender when prescribing FDC of pregabalin and nortriptyline in peripheral neuropathy patients? *

  18. What percentage of your patients report satisfactory compliance with FDC of pregabalin and nortriptyline treatment? *

  19. How do you typically monitor the effectiveness of FDC of pregabalin and nortriptyline treatment in your patients? *

  20. How satisfied are your patients with the response of the FDC of pregabalin and nortriptyline in managing their peripheral neuropathic pain? (5 being very satisfied) *

  21. How satisfied are your patients with the tolerability of the FDC of pregabalin and nortriptyline in managing their peripheral neuropathic pain? (5 being very satisfied) *

  22. In your experience, what are the different types of neuropathic pain where FDC of pregabalin and nortriptyline is more effective and why? *
  23. Do you find FDC of pregabalin and nortriptyline more effective than other medications commonly prescribed for neuropathy? *

  24. What percentage of adults exhibit satisfactory tolerance FDC of pregabalin and nortriptyline? *

  25. How do you assess the long-term efficacy of the FDC of pregabalin and nortriptyline in managing neuropathic pain?*
  26. What proportion of your neuropathy patients require dose titration with FDC of pregabalin and nortriptyline? *

  27. What percentage of your neuropathy patients experience significant improvement in sleep quality with FDC of pregabalin and nortriptyline? *

  28. How frequently do you encounter patients who discontinue FDC of pregabalin and nortriptyline due to lack of efficacy? *

  29. In your experience, do patients with neuropathic pain having comorbidities influence your decision to prescribe FDC of pregabalin and nortriptyline and Why? *
  30. Based on your experience, do you think additional research is needed to better understand FDC of pregabalin and nortriptyline in neuropathy management? *

  31. In your opinion, what advantage does FDC of pregabalin and nortriptyline offer over other combinations in neuropathy management? *
  32. How would you rate your overall experience with prescribing FDC of pregabalin and nortriptyline in neuropathy management? (5 being very satisfied) *

  33. How do you adjust the treatment plan based on the disease progression? *